Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Kisan Ratilal Choksey Shares and Securities Private Limited
$58.00
Provider: Motilal Oswal Securities Ltd.
$69.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ranbaxy Laboratories Ltd may face fine in US for violations at Toansa-Business Standard


Thursday, 21 Aug 2014 09:26am EDT 

Ranbaxy Laboratories Ltd:Will have to pay a hefty fine of around 2.42 bln Indian Rupees to the US authorities on account of violations found at its active pharmaceutical ingredient (API) manufacturing factory in Toansa (Punjab)-Business Standard.The facility is currently banned from supplying products to the American market.